Metrion Biosciences Appoints Mark Keogh as Non-Executive Director
Appointment strengthens the financial and corporate experience of Metrion s Board in support of the Company s planned international growth
Metrion Biosciences Limited ( Metrion ), the specialist ion channel contract research and drug discovery company, today announced the appointment of Mark Keogh as a Non-Executive Director. The appointment follows the Company s recently announced £2.7m new equity investment led by Gresham House Ventures and is intended to strengthen the Board s financial and corporate experience, in support of the Company s planned international growth.
Mark is a chartered accountant and civil engineer with more than 30 years experience of senior finance management in multiple industrial sectors. Most recently he was Group Chief Financial Officer of Charles Taylor plc, where he facilitated the group s rapid growth through multiple acquisitions and played a significant part in its eventual buy o